|
1
|
Väänänen HK, Zhao H, Mulari M and Halleen
JM: The cell biology of osteoclast function. J Cell Sci.
113:377–381. 2000.PubMed/NCBI
|
|
2
|
Blair HC and Athanasou NA: Recent advances
in osteoclast biology and pathological bone resorption. Histol
Histopathol. 19:189–199. 2004.PubMed/NCBI
|
|
3
|
Boyle WJ, Simonet WS and Lacey DL:
Osteoclast differentiation and activation. Nature. 423:337–342.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cuetara BV, Crotti TN, O’Donoghue AJ and
McHugh KP: Cloning and characterization of osteoclast precursors
from the RAW264.7 cell line. In Vitro Cell Dev Biol Anim.
42:182–188. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
MacDonald BR, Takahashi N, et al:
Formation of multinucleated cells that respond to osteotropic
hormones in long term human bone marrow cultures. Endocrinology.
120:2326–2333. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Udagawa N, Takahashi N, Akatsu T, et al:
Origin of osteoclasts: mature monocytes and macrophages are capable
of differentiating into osteoclasts under a suitable
microenvironment prepared by bone marrow-derived stromal cells.
Proc Natl Acad Sci USA. 87:7260–7264. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Higuchi S, Tabata N, Tajima M, et al:
Induction of human osteoclast-like cells by treatment of blood
monocytes with anti-fusion regulatory protein-1/CD98 monoclonal
antibodies. J Bone Miner Res. 13:44–49. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Halleen JM, Alatalo SL, Suominen H, et al:
Tartrate-resistant acid phosphatase 5b: a novel serum marker of
bone resorption. J Bone Miner Res. 15:1337–1345. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Halleen JM, Tiitinen SL, Ylipahkala H,
Fagerlund KM and Väänänen HK: Tartrate-resistant acid phosphatase
5b (TRACP 5b) as a marker of bone resorption. Clin Lab. 52:499–509.
2006.PubMed/NCBI
|
|
10
|
Alatalo SL, Halleen JM, et al: Rapid
screening method for osteoclast differentiation in vitro that
measures tartrate-resistant acid phosphatase 5b activity secreted
into the culture medium. Clin Chem. 46:1751–1754. 2000.PubMed/NCBI
|
|
11
|
Rissanen JB, Suominen MI, Peng ZQ and
Halleen JM: Secreted tartrate-resistant acid phosphatase 5b is a
marker of osteoclast number in human osteoclast cultures and the
rat ovariectomy model. Calcif Tissue Int. 82:108–115. 2008.
View Article : Google Scholar
|
|
12
|
Hsu H, Lacey DL, Dunstan CR, et al: Tumor
necrosis factor receptor family member RANK mediates osteoclast
differentiation and activation induced by osteoprotegerin ligand.
Proc Natl Acad Sci USA. 96:3540–3545. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thompson CD, Frazier-Jessen MR, Rawat R,
Nordan RP and Brown RT: Evaluation of methods for transient
transfection of a murine macrophage cell line, RAW 264.7.
Biotechniques. 27:824–832. 1999.PubMed/NCBI
|
|
14
|
Yu X, Huang Y, Collin-Osdoby P and Osdoby
P: CCR1 chemokines promote the chemotactic recruitment, RANKL
development, and motility of osteoclasts and are induced by
inflammatory cytokines in osteoblasts. J Bone Miner Res.
19:2065–2077. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Battaglino R, Fu J, Späte U, et al:
Serotonin regulates osteoclast differentiation through its
transporter. J Bone Miner Res. 19:1420–1431. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mose S, Menzel C, Kurth AA, et al:
Evaluation of tartrate-resistant acid phosphatase (TRACP) 5b as
bone resorption marker in irradiated bone metastases. Anticancer
Res. 25:4639–4645. 2005.PubMed/NCBI
|
|
17
|
Qin YJ, Zhang ZL, Zhang H, et al:
Age-related changes of serum tartrate-resistant acid phosphatase 5b
and the relationship with bone mineral density in Chinese women.
Acta Pharmacol Sin. 29:1493–1498. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nenonen A, Cheng S, Ivaska KK, et al:
Serum TRACP 5b is a useful marker for monitoring alendronate
treatment: comparison with other markers of bone turnover. J Bone
Miner Res. 20:1804–1812. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Alatalo SL, Ivaska KK, Waguespack SG, et
al: Osteoclast-derived serum tartrate-resistant acid phosphatase 5b
in Albers-Schonberg disease (type II autosomal dominant
osteopetrosis). Clin Chem. 50:883–890. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alatalo SL, Ivaska KK, Peng Z, et al:
Serum tartrate-resistant acid phosphatase 5b and osteocalcin in
naturally occurring osteopetrotic rats. J Bone Miner Res.
18(Suppl): S952003. View Article : Google Scholar
|
|
21
|
Xiao XH, Liao EY, Zhou HD, et al: Ascorbic
acid inhibits osteoclastogenesis of RAW264.7 cells induced by
receptor activated nuclear factor kappaB ligand (RANKL) in vitro. J
Endocrinol Invest. 28:253–260. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Abe K, Yoshimura Y, Deyama Y, et al:
Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells.
Int J Mol Med. 29:1007–1015. 2012.PubMed/NCBI
|
|
23
|
Teramachi J, Morimoto H, Baba R, et al:
Double stranded RNA-dependent protein kinase is involved in
osteoclast differentiation of RAW264.7 cells in vitro. Exp Cell
Res. 316:3254–3262. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
GuezGuez A, Prod’homme V, Mouska X, et al:
3BP2 Adapter protein is required for receptor activator of NF
kappaB ligand (RANKL)-induced osteoclast differentiation of
RAW264.7 cells. J Biol Chem. 285:20952–20963. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nishida T, Emura K, Kubota S, Lyons KM and
Takigawa M: CCN family 2/connective tissue growth factor
(CCN2/CTGF) promotes osteoclastogenesis via induction of and
interaction with dendritic cell-specific transmembrane protein
(DC-STAMP). J Bone Miner Res. 26:351–363. 2011. View Article : Google Scholar
|
